|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaids and other | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Convertible note payable - net | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued interest payable (includes related parties interest of $1,280,143 and $1,032,536 respectively) | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Advances | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total advances | ||||||||||||||||||||
| Advances - others | ||||||||||||||||||||
| Customer deposits | ||||||||||||||||||||
| Legal Settlement Liability | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Common stock - $0.0001 par value, 500,000,000 shares authorized 464,871,204 and 456,361,204 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...